Sheila Rajagopal, MD, The University of Chicago, Chicago, IL, discusses the critical need to diversify populations represented in cancer genomics research and for the development of novel tools for precision medicine in more diverse populations of patients with breast cancer. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.